Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta‐analysis
- DOI
- 10.1111/bjh.70757
- Published
- 2026-08-23
- Container
- British Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70757,
title = {Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta‐analysis},
author = {Veer Shah and Darshi Shah and Payton Utzman and Karan Shah and Srivatsan Swaminathan and Maria Mainou and Rajshekhar Chakraborty and Aaron Goodman and Samer Al Hadidi and Amar H. Kelkar and Edward R. Scheffer Cliff and Ghulam Rehman Mohyuddin},
year = {2026},
journal = {British Journal of Haematology},
doi = {10.1111/bjh.70757},
url = {https://doi.org/10.1111/bjh.70757}
}RIS
TY - JOUR TI - Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta‐analysis AU - Veer Shah AU - Darshi Shah AU - Payton Utzman AU - Karan Shah AU - Srivatsan Swaminathan AU - Maria Mainou AU - Rajshekhar Chakraborty AU - Aaron Goodman AU - Samer Al Hadidi AU - Amar H. Kelkar AU - Edward R. Scheffer Cliff AU - Ghulam Rehman Mohyuddin PY - 2026 JO - British Journal of Haematology DO - 10.1111/bjh.70757 UR - https://doi.org/10.1111/bjh.70757 ER -
APA
Shah, V., Shah, D., Utzman, P., Shah, K., Swaminathan, S., Mainou, M., Chakraborty, R., Goodman, A., Hadidi, S. A., Kelkar, A. H., Cliff, E. R. S., & Mohyuddin, G. R. (2026). Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta‐analysis. British Journal of Haematology. https://doi.org/10.1111/bjh.70757
Source records
- crossref · retrieved 2026-09-25T22:49:07.791Z